Analysis of Residual Solvents in drug products

Importance of the Topic

Residual solvents in pharmaceuticals can pose significant health risks if present above acceptable levels. The USP <467> Procedure A specifies a headspace gas chromatography method to detect and quantify Class 1 solvents, ensuring product safety and regulatory compliance.

Objectives and Study Overview

This application note demonstrates the use of a Shimadzu GC-2030 coupled with an HS-20 headspace sampler and FID-2030 detector to analyze five Class 1 residual solvents in drug products. The goal is to validate the method’s performance in terms of separation, sensitivity, and reproducibility.

Applied Instrumentation

• Gas chromatograph: Nexis™ GC-2030
• Detector: FID-2030
• Headspace sampler: HS-20
• Column: SH-I-624Sil MS, 30 m × 0.32 mm ID, 1.8 µm film

Methodology

• GC oven program: 40 °C hold 20 min, ramp 10 °C/min to 240 °C, hold 20 min (total 60 min)
• Injection: split 1:5, 1 µL sample, He carrier gas at 35 cm/s
• FID conditions: detector at 250 °C
• Headspace settings: vial 20 mL, incubation 80 °C for 60 min, pressurization 75 kPa for 1 min, load 1 min, transfer line 120 °C

Main Results and Discussion

The method achieved complete baseline separation of five Class 1 solvents—1,1-dichloroethane, 1,1,1-trichloroethane, carbon tetrachloride, benzene, and 1,2-dichloroethane—within a single analysis. The optimized headspace parameters provided consistent sample introduction and peak reproducibility. Detector response was linear across the relevant concentration range, meeting USP sensitivity requirements.

Benefits and Practical Applications

• Regulatory compliance: direct alignment with USP <467> guidelines
• High throughput: 60 min runtime accommodates routine batch testing
• Robustness: stable retention times and reproducible quantitation
• Flexibility: adaptable to additional solvent classes or matrix types

Future Trends and Potential Applications

Emerging advances may include faster chromatography through shorter, high-efficiency columns, integration of mass spectrometry for enhanced selectivity, and automated data processing with machine learning for real-time quality control. Miniaturized headspace systems and green analytical techniques may further streamline solvent screening in pharmaceutical workflows.

Conclusion

The Shimadzu GC-2030/HS-20 system with the SH-I-624Sil MS column provides a reliable, USP-compliant solution for quantifying Class 1 residual solvents in drug products. The method delivers consistent separation, sensitivity, and throughput suitable for quality control laboratories.

Reference

Application News G290 (JP, ENG), Shimadzu Corporation, First Edition: Sep. 2022, ERAS-1000-0310.